EBV-informed multi-omics target prioritization and structure-based drug repurposing reveal potential therapeutic strategies for multiple sclerosis.

Lal NM, Sajal H, Mohan A, R A, Fathima F, Raju R, Nadh AG

Funct Integr Genomics. 2026 Jul 09; 26(1). PMID: 42420581. Abstract